Aims to enhance Frontage's global lab service capabilities and strengthen its presence in China and the Asia-Pac region.

XyloCor Therapeutics Inc. has appointed John Tucker as President and Chief Executive Officer (CEO), effective immediately.

Novartis has unveiled plans to establish a new 46,000-square-foot radioligand therapy (RLT) manufacturing site in Denton, ...

Upperton has submitted an application to the UK’s Medicines and Healthcare Products Regulatory Agency for approval of its new ...

Arcutis Biotherapeutics is promoting Mas Matsuda, senior vice president and general counsel, to executive VP and chief legal ...

Invivyd, which focuses on protection against viral infectious diseases, is naming Michael Mina, MD, PhD, chief medical ...

SmartSkin Technologies has introduced SmartSkin Seal Assurance, a solution designed to give pharmaceutical manufacturers real ...

Therna Biosciences has joined forces with Charles River to advance single-patient RNA medicines for individuals with severe, ...

Codexis has agreed to manufacture 50 grams of siRNA using its proprietary ECO Synthesis manufacturing platform to support ...

Fujifilm Biotechnologies is unveiling a precision purification tool, ShunzymeX, that simplifies downstream processing for ...

Moderna has entered into a settlement agreement resolving all worldwide Arbutus Biopharma Corporation/Genevant Sciences GmbH ...

Hoth Therapeutics has deployed the OpenAI API to support IND-enabling development of HT-KIT, its orphan-designated therapy ...